Graham Capital Management, L.P. Evolus, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Evolus, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 17,194 shares of EOLS stock, worth $278,886. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,194
Previous 16,255
5.78%
Holding current value
$278,886
Previous $227,000
18.06%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding EOLS
# of Institutions
163Shares Held
49.1MCall Options Held
453KPut Options Held
14K-
Perceptive Advisors LLC New York, NY5.75MShares$93.3 Million1.81% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$78.6 Million6.42% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$65 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$48.4 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$47.2 Million2.11% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $910M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...